Connection

Kamlesh Khunti to Glucosides

Back to Details
This is a "connection" page, showing publications Kamlesh Khunti has written about Glucosides.
Kamlesh Khunti
Connection Strength
0.223
Glucosides
  1. Sodium-glucose co-transporter-2 inhibitors and cardiovascular outcome studies in people with type 2 diabetes: From efficacy to effectiveness. Diabetes Obes Metab. 2018 04; 20(4):763-765.
    View in: PubMed
    Score: 0.127
  2. Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10. Diabetes Care. 2018 06; 41(6):e106-e108.
    View in: PubMed
    Score: 0.033
  3. SGLT2 inhibitors and renal outcomes in type 2 diabetes with or without renal impairment: A systematic review and meta-analysis. Prim Care Diabetes. 2018 06; 12(3):265-283.
    View in: PubMed
    Score: 0.032
  4. Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors). Circulation. 2017 Jul 18; 136(3):249-259.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.